KNSA Kiniksa Pharmaceuticals International, plc
KNSA Kiniksa Pharmaceuticals International, plc
Healthcare · Drug Manufacturers - Specialty & Generic
Market read
Scan convergence 1 scan as of 2026-10-23 1 neutral converging
POC $42.33 · VWAP $55.69 · +37.8% vs 12m avg buyer
Insiders quiet 0 buy / 0 sell · Form 4, 90d
Coverage
1 watchlist
KNSA Price Structure
Loading timeframes…
Peers
Every watchlist KNSA belongs to, members best 30-day change first — KNSA highlighted in place. Each pill: 30d change, 1d/7d, and a close spark over the last 30 calendar days (~21 sessions); hover for price, RSI, and the full chart.
@monster-discoveries
Reported EPS $0.30 versus analyst consensus of $0.28 (+5.3%).
full note →Against street estimates
How KNSA's reported EPS compared with analyst consensus. Street estimates are single-source vendor consensus (yfinance). Actuals are vendor consensus-basis EPS (often non-GAAP); edgarEps is GAAP diluted from filings — disputed flags large disagreement only. A consensus out of line with the name's earlier estimates (opposite sign to all of them and over 3x their size) is not graded. EPS only.
KNSA research tape
71 dated scans, research, and events, newest first — the full record. Desk commentary and scheduled prints sit in their own panes.